Yanina Grant-Huerta - 09 Mar 2026 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Signature
/s/ John Chao, Attorney-in-Fact for Yanina Grant-Huerta
Issuer symbol
ATRA
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 17:45:38 UTC
Previous filing
04 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Grant-Huerta Yanina Chief Accounting Officer C/O ATARA BIOTHERAPEUTICS, INC., 1280 RANCHO CONEJO BOULEVARD, THOUSAND OAKS /s/ John Chao, Attorney-in-Fact for Yanina Grant-Huerta 11 Mar 2026 0002064348

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award +20,300 +64% $0.000000* 52,050 09 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following March 9, 2026, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares subject to the RSUs shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous employment. "Quarterly Vesting Date" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date.